(Q37642763)

21 August 2017

1 reference

title

Treatment strategies for juvenile idiopathic arthritis (English)

1 reference

juvenile rheumatoid arthritis

21 August 2017

1 reference

Ariane Klein

1

1 reference

21 August 2017

Gerd Horneff

series ordinal

2

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 December 2009

1 reference

Expert Opinion on Pharmacotherapy

21 August 2017

1 reference

21 August 2017

10

1 reference

21 August 2017

18

1 reference

21 August 2017

3049-3060

1 reference

The efficacy and safety of intraarticular corticosteroid therapy for coxitis in juvenile rheumatoid arthritis

21 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14656560903386300

Triamcinolone acetonide and hexacetonide intra-articular treatment of symmetrical joints in juvenile idiopathic arthritis: a double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903386300

Penicillamine and hydroxychloroquine in the treatment of severe juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903386300

Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children's Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903386300

Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903386300

A 26 week randomised, double blind, placebo controlled exploratory study of sulfasalazine in juvenile onset spondyloarthropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903386300

Sulphasalazine-induced systemic lupus erythematous in a patient with ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903386300

Leflunomide or methotrexate for juvenile rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903386300

The German etanercept registry for treatment of juvenile idiopathic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903386300

Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903386300

Juvenile idiopathic arthritis and uveitis: screening and anti-inflammatory therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903386300

Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903386300

Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903386300

Effectiveness of a once weekly double dose of etanercept in patients with juvenile idiopathic arthritis: a clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903386300

Safety and efficacy of once weekly etanercept 0.8 mg/kg in a multicentre 12 week trial in active polyarticular course juvenile idiopathic arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903386300

Adalimumab with or without methotrexate in juvenile rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903386300

Tuberculosis in a nine-year-old girl treated with infliximab for systemic juvenile idiopathic arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903386300

Anakinra in the treatment of polyarticular-course juvenile rheumatoid arthritis: safety and preliminary efficacy results of a randomized multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903386300

Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903386300

Prevention and reversal of nephritis in MRL/lpr mice with a single injection of C-reactive protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903386300

Use of canakinumab in the cryopyrin-associated periodic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903386300

The impact of glycosylation on HLA-DR1-restricted T cell recognition of type II collagen in a mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903386300

Tolerogenic immune responses to novel T-cell epitopes from heat-shock protein 60 in juvenile idiopathic arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903386300

Heat-shock protein 60 as a tool for novel therapeutic strategies that target the induction of regulatory T cells in human arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903386300

Epitope-specific immunotherapy induces immune deviation of proinflammatory T cells in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903386300

Switching the therapy from etanercept to infliximab in a child with rheumatoid factor positive polyarticular juvenile idiopathic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903386300

Golimumab in patients with active rheumatoid arthritis despite treatment with methotrexate: A randomized, double-blind, placebo-controlled, dose-ranging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903386300

A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903386300

10.1517/14656560903386300

21 January 2018

Identifiers

DOI

1 reference

release_k4h7ac7nknh27cp4wnexpqjiay

21 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/k4h7ac7nknh27cp4wnexpqjiay

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference